These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34321108)

  • 1. The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients.
    Lucas P; Boyd S; Milloy MJ; Walsh Z
    J Cannabis Res; 2021 Jul; 3(1):34. PubMed ID: 34321108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles.
    Fedorova EV; Schrager SM; Robinson LF; Cepeda A; Wong CF; Iverson E; Lankenau SE
    Drug Alcohol Depend; 2019 May; 198():21-27. PubMed ID: 30861391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study.
    Gali K; Winter SJ; Ahuja NJ; Frank E; Prochaska JJ
    Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):16. PubMed ID: 33579324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Marijuana Legalization on Opioid Utilization in Patients Diagnosed with Pain.
    Neilson LM; Swift C; Swart ECS; Huang Y; Parekh N; Munshi KD; Henderson R; Good CB
    J Gen Intern Med; 2021 Nov; 36(11):3417-3422. PubMed ID: 33575906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada.
    Lucas P; Walsh Z; Hendricks PS; Boyd S; Milloy MJ
    J Subst Abuse Treat; 2021 Nov; 130():108481. PubMed ID: 34118713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience.
    Rubin-Kahana DS; Crépault JF; Matheson J; Le Foll B
    Front Psychiatry; 2022; 13():984485. PubMed ID: 36213917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study.
    McCarthy SDS; Xiao J; Pugliese M; Perrault-Sequeira L; Myran DT
    Lancet Reg Health Am; 2024 Aug; 36():100815. PubMed ID: 38974381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study.
    Reddon H; Fast D; DeBeck K; Werb D; Hayashi K; Wood E; Milloy MJ
    Int J Drug Policy; 2019 Jul; 69():16-23. PubMed ID: 31015080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home cultivation across Canadian provinces after cannabis legalization.
    Wadsworth E; Cristiano N; Pacheco K; Jesseman R; Hammond D
    Addict Behav Rep; 2022 Jun; 15():100423. PubMed ID: 35434251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
    AminiLari M; Busse JW; Turna J; MacKillop J
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1133-1139. PubMed ID: 35333612
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug use in Canadian patients with trauma after cannabis legalization.
    Ball IM; Priestap F; Parry N; Pace J; Vogt KN
    Can J Surg; 2021 Jul; 64(4):E403-E406. PubMed ID: 34296708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
    Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
    JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients.
    Lucas P; Baron EP; Jikomes N
    Harm Reduct J; 2019 Jan; 16(1):9. PubMed ID: 30691503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis.
    Gorfinkel LR; Stohl M; Greenstein E; Aharonovich E; Olfson M; Hasin D
    Addiction; 2021 May; 116(5):1113-1121. PubMed ID: 33029914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic.
    Roth W; Tam M; Bi C; Kim J; Lewis J; Ho R; Apollonio DE
    Clin Toxicol (Phila); 2022 May; 60(5):632-638. PubMed ID: 34871128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.